Copyright
©The Author(s) 2019.
World J Clin Oncol. Mar 24, 2019; 10(3): 136-148
Published online Mar 24, 2019. doi: 10.5306/wjco.v10.i3.136
Published online Mar 24, 2019. doi: 10.5306/wjco.v10.i3.136
Figure 1 Polymerase chain reaction-restriction fragment length polymorphism analysis of fibroblast growth factor receptor 4 G388 gene.
Five individual tissue specimen of Head and Neck Squmous Cell Carcinoma are presented. Line 2 shows a homozygote carrier for the Glycine allele, the dominant form of the fibroblast growth factor receptor 4 (FGFR4). Lane 1, 3 and 5 show a heterozygote carrier of the FGFR4 with both alleles glycine388 and arginine388. Lane 4 shows a homozygous carrier for the arginine allele.
- Citation: Wimmer E, Ihrler S, Gires O, Streit S, Issing W, Bergmann C. Fibroblast growth factor receptor 4 single nucleotide polymorphism Gly388Arg in head and neck carcinomas. World J Clin Oncol 2019; 10(3): 136-148
- URL: https://www.wjgnet.com/2218-4333/full/v10/i3/136.htm
- DOI: https://dx.doi.org/10.5306/wjco.v10.i3.136